Testing effectiveness (Phase 2)Study completedNCT03535168What this trial is testingRepeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough PatientsWho this might be right forCough Bayer 59
Early research (Phase 1)Ended earlyNCT02289482What this trial is testingA Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsWho this might be right forInfection, Human Immunodeficiency Virus GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT01949103What this trial is testingTD-1607 MAD Study in Healthy SubjectsWho this might be right forInfectionsBacterial Infections Theravance Biopharma 48
Early research (Phase 1)Study completedNCT01764178What this trial is testingTo Evaluate the Safety and PK Characteristics in Healthy Volunteers-LivalozetWho this might be right forHyperlipidemiaHypertension JW Pharmaceutical 52
Early research (Phase 1)Study completedNCT00958503What this trial is testingEffect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied TissueWho this might be right forHealthy Psyadon Pharma 30
Early research (Phase 1)Study completedNCT02291991What this trial is testingStudy to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy SubjectsWho this might be right forHealthy Genexine, Inc. 10
Early research (Phase 1)Study completedNCT03649997What this trial is testingSingle and Multiple Ascending Doses of JNJ-61393215 in Healthy ParticipantsWho this might be right forHealthy Janssen Research & Development, LLC 57
Early research (Phase 1)Active Not RecruitingNCT07200986What this trial is testingStudy to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy SubjectsWho this might be right forHealthy Participants Celltrion 218
Early research (Phase 1)Study completedNCT02088918What this trial is testingA Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male SubjectsWho this might be right forHealthy Volunteers IlDong Pharmaceutical Co Ltd 40
Early research (Phase 1)Study completedNCT05845996What this trial is testingStudy of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult SubjectsWho this might be right forHealthy Volunteers Sanofi 56
Early research (Phase 1)Study completedNCT07200596What this trial is testingThe Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy SubjectsWho this might be right forRheumatoid Arthritis (RA) Guangdong Hengrui Pharmaceutical Co., Ltd 16
Early research (Phase 1)Study completedNCT03055962What this trial is testingStudy to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese SubjectsWho this might be right forHealthy Participants Eisai Co., Ltd. 16
Early research (Phase 1)Study completedNCT05523570What this trial is testingEvaluate the Safety, Tolerability, PK and PD of HNC364 Injectable SuspensionWho this might be right forParkinson's Disease Guangzhou Henovcom Bioscience Co. Ltd. 34
Early research (Phase 1)Study completedNCT00935831What this trial is testingSingle Dose Safety Study for Compound to Treat Anemia in Patients With Renal ImpairmentWho this might be right forKidney Disease GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT02690142What this trial is testingInvestigate the Safety, Tolerability and Pharmacokinetics of ABY-035Who this might be right forPsoriasisHealthy Subjects Affibody 72
Early research (Phase 1)Study completedNCT03252002What this trial is testingClinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male SubjectsWho this might be right forHealthy Volunteer Bayer 96
Very early researchStudy completedNCT03105375What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose StudyWho this might be right forHealthy Volunteers Cinclus Pharma AG 39
Early research (Phase 1)Study completedNCT00950105What this trial is testingSingle Ascending Dose Study of Oral CPSI-2364 (Semapimod)Who this might be right forCrohn's Disease Ferring Pharmaceuticals 30
Early research (Phase 1)Study completedNCT01478503What this trial is testingTo Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly FemalesWho this might be right forPharmacokineticsHealthy Subjects Astellas Pharma Inc 96
Early research (Phase 1)Ended earlyNCT01473069What this trial is testingTwo Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy SubjectsWho this might be right forHealthy Akros Pharma Inc. 41